Autologous transplantation with peripheral blood stem cells in chronic lymphocytic leukemia. A phase III, randomized, multicenter study. GIMEMA. Gruppo Italiano per le Malattie Ematologiche dell'Adulto. GITMO-Gruppo Italiano Trapianto di Midollo Osseo.
D000328:Adult; D018952:Antigens, CD34 / Q000032:analysis; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002985:Clinical Protocols; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000494:pharmacology; D004358:Drug Therapy; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000494:pharmacology; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007558:Italy; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy*; D008875:Middle Aged; D010641:Phenotype; D010865:Pilot Projects; D011446:Prospective Studies; D013223:Statistics as Topic; D015996:Survival Rate; D018675:Toxicity Tests; D014182:Transplantation, Autologous; D014740:Vidarabine / Q000031:analogs & derivatives / Q000627:therapeutic use
D018952:Antigens, CD34; D000970:Antineoplastic Agents; D016179:Granulocyte Colony-Stimulating Factor; D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine